ALZHEIMER'S DISEASE RESEARCH FOUNDATION
ALZHEIMER'S DISEASE RESEARCH FOUNDATION
WELLESLEY HILLS, MA, US
•
a.k.a ALZHEIMER'S DISEASE RESEARCH FOUNDATION
•
501(c)(3)
•
EIN
52-2396428
•
ALZHEIMER'S DISEASE RESEARCH FOUNDATION
WELLESLEY HILLS, MA, US
•
a.k.a ALZHEIMER'S DISEASE RESEARCH FOUNDATION
•
501(c)(3)
•
EIN
52-2396428
•
Programs
Alzheimer's Disease Research Support
IN 2021, CURE ALZHEIMER'S FUND SUPPORTED 77 RESEARCH PROJECTS AT 39 LEADING RESEARCH INSTITUTIONS, FOR RESEARCH OUTPUT OF MORE THAN $17 MILLION. MANY PROJECTS PURSUED A DEEPER UNDERSTANDING OF THE MECHANISMS OF ACTION OF THE GENES AND VARIANTS WITH THE BIGGEST IMPACT ON RISK AND TIMING OF ALZHEIMER'S DISEASE. OTHER PROJECTS PURSUED NOVEL THEORIES AND TOOLS TO ASSESS POTENTIAL AVENUES FOR PREVENTION AND TREATMENT, IN PARTICULAR REGARDING THE ROLE OF THE BRAIN'S INNATE IMMUNE SYSTEM AND THE CONTROL OF THE ENTRY AND EXIT OF MATERIALS FOR HEALTHY BRAIN FUNCTION. ADDITIONAL EXPENSES INCLUDE HUSBANDRY OF TRANSGENIC ANIMAL MODELS BY A CONTRACT RESEARCH ORGANIZATION; THE DIRECT SUPPORT OF FACILITATING GRANTS AND THE AWARD PROCESS; AND COSTS ASSOCIATED WITH ASSESSING RESEARCH PROPOSALS AND DETERMINING FUNDING PRIORITIES.GeographiesNot indicatedDatesJan 1, 2021 – Dec 31, 2021Source990No causes providedNo populations provided–$17.7MAlzheimer's Awareness Campaign
CREATING AWARENESS TOOK THE FORM OF MAILINGS, OUTREACH, AND SUPPORT OF THIRD PARTY EVENTS DESIGNED TO RAISE AWARENESS ABOUT THE NEED OF MORE RESEARCH INTO THE ORIGINS AND PROGRESSION OF ALZHEIMER'S DISEASE.GeographiesNot indicatedDatesJan 1, 2021 – Dec 31, 2021Source990No causes providedNo populations provided–$3MProgram 1 [2024]
IN 2024, CURE ALZHEIMER'S FUND SUPPORTED 120 RESEARCH PROJECTS AT 66 LEADING RESEARCH INSTITUTIONS, FOR RESEARCH OUTPUT OF $30 MILLION. MANY PROJECTS PURSUED A DEEPER UNDERSTANDING OF THE MECHANISMS OF ACTION OF THE GENES AND VARIANTS WITH THE BIGGEST IMPACT ON RISK AND TIMING OF ALZHEIMER'S DISEASE. OTHER PROJECTS PURSUED NOVEL THEORIES AND TOOLS TO ASSESS POTENTIAL AVENUES FOR PREVENTION AND TREATMENT, IN PARTICULAR REGARDING THE ROLE OF NEUROINFLAMMATION, THE GUT MICROBIOME, AND THE IMMUNE SYSTEM IN HEALTHY BRAIN FUNCTION. ADDITIONAL EXPENSES INCLUDE HUSBANDRY OF TRANSGENIC ANIMAL MODELS BY A CONTRACT RESEARCH ORGANIZATION; THE DIRECT SUPPORT OF FACILITATING GRANTS AND THE AWARD PROCESS; AND COSTS ASSOCIATED WITH ASSESSING RESEARCH PROPOSALS AND DETERMINING FUNDING PRIORITIES.GeographiesNot indicatedDatesJan 1, 2024 – Dec 31, 2024Source990No causes providedNo populations provided–$30M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)